• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度乳腺癌的激素受体状态:798例肿瘤的研究

Hormone receptor status of breast cancer in India: a study of 798 tumours.

作者信息

Desai S B, Moonim M T, Gill A K, Punia R S, Naresh K N, Chinoy R F

机构信息

Department of Pathology, Tata Memorial Hospital, Mumbai-400 012, India.

出版信息

Breast. 2000 Oct;9(5):267-70; discussion 270. doi: 10.1054/brst.2000.0134.

DOI:10.1054/brst.2000.0134
PMID:14732176
Abstract

The objectives of this study were to document the oestrogen and progesterone receptor (ER & PR) status of breast cancer in the Indian population (as done by immunohistochemistry on paraffin blocks), and correlate the steroid receptor status of breast cancer with all relevant patient and tumour characteristics. Our current data have been compared with previously published data from other centres. In contrast to the higher rates reported in the Western literature, only 32.6% of our tumours were ER positive and 46.1% were PR positive. Tumours were separated into four categories: ER+PR+ (25%), ER+PR- (7.4%), ER-PR+ (21.1%) and ER-PR- (46.5%). ER and PR immunoreactivity increased with advancing age, and correlated with the presence of elastosis. Infiltrating lobular carcinoma, mucinous carcinoma, and mixed tumours were more frequently ER & PR positive. High-grade infiltrating duct carcinomas, pure comedo ductal carcinoma in situ, and medullary carcinoma were predominantly ER & PR negative. The presence of necrosis and lymphovascular invasion showed an inverse relationship with ER and PR reactivity.

摘要

本研究的目的是记录印度人群乳腺癌的雌激素和孕激素受体(ER & PR)状态(通过对石蜡块进行免疫组织化学检测),并将乳腺癌的类固醇受体状态与所有相关的患者和肿瘤特征进行关联。我们目前的数据已与其他中心先前发表的数据进行了比较。与西方文献报道的较高比例相比,我们的肿瘤中只有32.6%为ER阳性,46.1%为PR阳性。肿瘤被分为四类:ER+PR+(25%)、ER+PR-(7.4%)、ER-PR+(21.1%)和ER-PR-(46.5%)。ER和PR免疫反应性随年龄增长而增加,并与弹性组织变性的存在相关。浸润性小叶癌、黏液癌和混合性肿瘤的ER和PR阳性更为常见。高级别浸润性导管癌、单纯粉刺型导管原位癌和髓样癌主要为ER和PR阴性。坏死和淋巴管浸润的存在与ER和PR反应性呈负相关。

相似文献

1
Hormone receptor status of breast cancer in India: a study of 798 tumours.印度乳腺癌的激素受体状态:798例肿瘤的研究
Breast. 2000 Oct;9(5):267-70; discussion 270. doi: 10.1054/brst.2000.0134.
2
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.使用定量氟-18氟脱氧葡萄糖/正电子发射断层扫描成像参数比较三阴性乳腺癌与雌激素受体阳性/孕激素受体阳性/人表皮生长因子受体2阴性乳腺癌:一种对疾病特征描述可能有用的方法。
Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226.
3
Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive.可手术乳腺癌的腋窝淋巴结状态与类固醇受体及HER-2状态的联合关系:三阳性肿瘤更易出现淋巴结阳性。
Breast Cancer Res Treat. 2009 Jan;113(1):181-7. doi: 10.1007/s10549-008-9914-7. Epub 2008 Feb 9.
4
High incidence of oestrogen receptor negative progesterone receptor positive phenotype in Indian breast cancer: fact or fiction?印度乳腺癌中雌激素受体阴性孕激素受体阳性表型的高发生率:事实还是虚构?
Indian J Pathol Microbiol. 2005 Apr;48(2):199-201.
5
Relationship between hormone receptor status and tumour size, grade and comedo necrosis in ductal carcinoma in situ.导管原位癌中激素受体状态与肿瘤大小、分级及粉刺样坏死之间的关系。
Br J Surg. 2005 Apr;92(4):429-34. doi: 10.1002/bjs.4878.
6
[Anatomopathology of breast cancer and hormone receptors].[乳腺癌与激素受体的解剖病理学]
Pathol Biol (Paris). 1983 Nov;31(9):747-54.
7
Breast carcinoma in women 35 years and younger: a pathological study.35岁及以下女性乳腺癌:一项病理学研究。
Pathology. 2006 Jun;38(3):219-22. doi: 10.1080/00313020600699268.
8
Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related.雌激素依赖性乳腺癌中HER-2/neu与孕激素受体之间的关联与年龄相关。
Breast Cancer Res Treat. 2005 May;91(1):81-7. doi: 10.1007/s10549-004-8235-8.
9
Correlation of steroid hormone receptor status with histological and nuclear grading in breast carcinoma.乳腺癌中类固醇激素受体状态与组织学及核分级的相关性
J BUON. 2004 Apr-Jun;9(2):173-7.
10
Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.确定石蜡包埋乳腺癌中类固醇激素受体阳性肿瘤细胞分数大小的阈值测定
Cytometry B Clin Cytom. 2005 Mar;64(1):43-52. doi: 10.1002/cyto.b.20045.

引用本文的文献

1
Triple-Negative, HER2/Neu, and Ki67 Markers in Breast Cancer Patients Undergoing Standard of Care Treatment in India: Real-World Evidence on Tumor Aggressiveness and Survival Outcomes.印度接受标准治疗的乳腺癌患者中的三阴性、HER2/Neu和Ki67标志物:关于肿瘤侵袭性和生存结果的真实世界证据。
Cureus. 2025 Feb 9;17(2):e78798. doi: 10.7759/cureus.78798. eCollection 2025 Feb.
2
An Audit of Breast Conservation Surgery for Breast Cancer - a 7-Year Experience from Southern India.印度南部乳腺癌保乳手术的一项审计——7年经验
Indian J Surg Oncol. 2023 Jun;14(2):492-496. doi: 10.1007/s13193-022-01532-8. Epub 2022 Apr 18.
3
Breast cancer: age incidence, hormone receptor status and family history in Najaf, Iraq.
伊拉克纳杰夫的乳腺癌:年龄发病率、激素受体状态和家族史。
J Med Life. 2022 Oct;15(10):1318-1321. doi: 10.25122/jml-2022-0296.
4
Screening, Docking, and Molecular Dynamics Study of Natural Compounds as an Anti-HER2 for the Management of Breast Cancer.天然化合物作为抗HER2药物用于乳腺癌治疗的筛选、对接及分子动力学研究
Life (Basel). 2022 Oct 28;12(11):1729. doi: 10.3390/life12111729.
5
Cancer Treatment-Induced Bone Loss: Role of Denosumab in Non-Metastatic Breast Cancer.癌症治疗引起的骨质流失:地诺单抗在非转移性乳腺癌中的作用。
Breast Cancer (Dove Med Press). 2022 Jul 14;14:163-173. doi: 10.2147/BCTT.S353332. eCollection 2022.
6
Rate of Breast-Conserving Surgery vs Mastectomy in Breast Cancer: a Tertiary Care Centre Experience from South India.乳腺癌保乳手术与乳房切除术的比例:来自印度南部一家三级护理中心的经验
Indian J Surg Oncol. 2019 Mar;10(1):72-76. doi: 10.1007/s13193-018-0818-7. Epub 2018 Oct 16.
7
Practical consensus recommendations regarding the use of hormonal therapy in metastatic breast cancer.关于转移性乳腺癌激素治疗应用的实用共识建议。
South Asian J Cancer. 2018 Apr-Jun;7(2):137-141. doi: 10.4103/sajc.sajc_121_18.
8
Estrogen receptor, Progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: A retrospective study of 5436 women from a regional cancer center in South India.乳腺癌中雌激素受体、孕激素受体及人表皮生长因子受体2状态:对印度南部一家地区癌症中心5436名女性的回顾性研究
South Asian J Cancer. 2018 Jan-Mar;7(1):7-10. doi: 10.4103/sajc.sajc_211_17.
9
Estrogen receptor and progesterone receptor status of breast cancer patients of eastern India: A multi-institutional study.印度东部乳腺癌患者的雌激素受体和孕激素受体状态:一项多机构研究。
South Asian J Cancer. 2018 Jan-Mar;7(1):5-6. doi: 10.4103/sajc.sajc_60_17.
10
Impact of Addition of Digital Breast Tomosynthesis to Digital Mammography in Lesion Characterization in Breast Cancer Patients.数字乳腺断层合成技术联合数字乳腺钼靶摄影对乳腺癌患者病变特征的影响
Int J Appl Basic Med Res. 2018 Jan-Mar;8(1):33-37. doi: 10.4103/ijabmr.IJABMR_372_16.